Zusammenfassung
Die Dopamin-β-Hydroxylase-Aktivität im menschlichen Serum wurde nach der oralen Zufuhr von Fusarinsäure (50–300 mg) stark gehemmt.
References
H. Hidaka, T. Nagatsu, K. Takeya, T. Takeuchi, H. Suda, K. Kojiri, M. Matsuzaki andH. Umezawa, J. Antibiot. Tokyo22, 228 (1966).
T. Nagatsu, H. Hidaka, H. Kuzuya, K. Takeya, H. Umezawa, T. Takeuchi andH. Suda, Biochem. Pharmac.19, 35 (1970).
K. Okamoto andK. Aoki, Jap. Circul. J.27, 282 (1963).
I. Nagatsu, T. Nagatsu, K. Mizutani, H. Umezawa, M. Matsuzaki andT. Takeuchi, Nature Lond.230, 381 (1971).
F. Terasawa andM. Kameyama, Jap. Circul. J.35, 339 (1971).
R. Weinshilboum andJ. Axelrod, Circulation Res.28, 307 (1971).
M. Goldstein, L. S. Freedman andM. Bonnay, Experientia27, 632 (1971).
R. J. Connett andN. Kirshner, J. biol. Chem.245, 329 (1970).
We thankDr. S. Udenfriend (Roche Institute of Molecular Biology, Nutley) for his stimulus to initiate this investigation, andDr. J. Axelrod (National Institutes of Health, Bethesda) for his personal information about the assay of serum dopamineβ-hydroxylase. We also wish to acknowledge the assistance of MissY. Sudo with the preparation of phenylethanolamine N-methyltransferase and the technical assistance of MissY. Nishikawa and MissY. Shibahara.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nagatsu, T., Kato, T., Kuzuya, H. et al. Inhibition of human serum dopamineβ-hydroxylase after the oral administration of fusaric acid. Experientia 28, 779–780 (1972). https://doi.org/10.1007/BF01923125
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01923125